Status:
COMPLETED
Serum Basal Tryptase Levels in Healthy Children
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Basal Tryptasemia
Eligibility:
All Genders
Up to 17 years
Brief Summary
The National REference Center for MASTocytosis (CEREMAST), located at the Necker-Enfants Malades Hospital, is particularly interested in two groups of rare diseases whose common point is excessive act...
Detailed Description
The National REference Center for MASTocytosis (CEREMAST), located at the Necker-Enfants Malades Hospital, is particularly interested in two groups of rare diseases whose common point is excessive act...
Eligibility Criteria
Inclusion
- Minor patients aged 0-18
- Patient for whom a complete blood count (CBC) is carried out for their care in a surgery department (orthopedic, visceral, maxillofacial, neurology, cardiology surgery) at the Necker-Enfants Malades hospital
- Information and non-opposition of the subjects and of holders of parental authority subjects
Exclusion
- \- Patients hospitalized in departments other than surgery at Necker-Enfants Malades Hospital
Key Trial Info
Start Date :
April 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 24 2022
Estimated Enrollment :
402 Patients enrolled
Trial Details
Trial ID
NCT05323188
Start Date
April 21 2022
End Date
October 24 2022
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker-Enfants Malades
Paris, France, 75015